首页> 外文期刊>American Journal of Ophthalmology Case Reports >Malignant optic nerve glioma in a young woman with 7 year follow up without recurrence
【24h】

Malignant optic nerve glioma in a young woman with 7 year follow up without recurrence

机译:一个年轻女子的恶性视神经神经胶质瘤,7年的年轻女性随访没有复发

获取原文
           

摘要

PurposeTo report diagnostic and management challenges of a case of WHO Grade III glioma of the optic nerve occurring in an unusually young patient with more than 7 years of survival without recurrence.ObservationsAn 18-year-old woman reported rapidly progressive vision loss in the right eye in the setting of a right optic nerve lesion, central retinal artery occlusion, central retinal vein occlusion, and neovascularization of the optic disc. An orbital MRI with contrast demonstrated enhancement of the intraocular, intraorbital, and intracanalicular portion of the right optic nerve. Biopsy of a portion of the intraorbital optic nerve was negative, however, biopsy of the intracranial optic nerve confirmed WHO Grade III glioma (anaplastic astrocytoma). Although the tumor was excised, there remained positive margins at the optic chiasm. The patient was then managed with a combination of radiation and temozolomide. Postoperatively, the initial neovascularization of the optic nerve that had resolved, re-emerged with gliosis. In this setting a concern for intraorbital tumor arose and the globe was enucleated, definitively ruling out neoplasm. The patient has remained tumor free seven years after resection.Conclusions and importanceMalignant optic pathway glioma is rare and carries a high 5-year mortality rate. Diagnosis can be elusive given orbital MRI with contrast often appears to be non-specific. Inflammatory changes can be confounding such that a biopsy in the respective area will yield a negative pathologic result. Repeat biopsy is recommended if clinical suspicion is high. Combination treatment of optic nerve tumor resection, temozolomide and radiation has been effective in treating this patient who continues to be followed closely and has had no clinical or radiographic evidence of recurrence in over 7 years. The re-emergence of neovascularization with gliosis/fibrosis of the optic nerve, was driven by ischemia and further precipitated by radiation. To our knowledge this patient represents the youngest reported case of malignant optic nerve glioma with the longest reported survival in the literature to date (over seven years).
机译:Purposeto报告诊断和管理挑战的案例是谁在一个异常的年轻患者中发生的视神经发育道,在没有复发的7年的生存中发生的异常年轻患者。可能会报告右眼的迅速渐进的视力丧失在右视神经病变,中央视网膜动脉闭塞,中央视网膜静脉闭塞和光盘新血管形成的情况下。眶缘MRI具有对比度表明了右视神经的眼内,眶内和颅内部分的增强。然而,眶上视神经的一部分的活检是阴性的,然而,颅内视神经的活检证实了谁III级胶质瘤(内塑性星形细胞瘤)。虽然肿瘤被切除,但是在视神经中仍有阳性边缘。然后将患者用辐射和替替莫唑胺的组合进行管理。术后,初始新生血管的初始新生血管已经解决,重新出现了神经症。在这种情况下,对胎肾炎性肿瘤产生的担忧和全球均匀,明确地统治肿瘤。切除后七年患者仍然存在肿瘤。结论和进一步的术骨视神经胶质瘤是罕见的,并且具有高5年的死亡率。诊断可以难以忽视奥伯特MRI,对比度通常似乎是非特异性的。炎症变化可能是混杂的,使得各个区域中的活组织检查将产生阴性病理结果。如果临床怀疑高,建议重复活检。视神经肿瘤切除的组合治疗,替替莫唑胺和辐射在治疗持续遵循的患者持续术后,并且没有超过7年的复发的临床或射线照相证据。通过缺血驱动的脊髓源性/纤维化的新血管或纤维化的再出现,并通过辐射进一步沉淀。据我们所知,该患者代表最年轻的恶性视神经胶质瘤,其迄今为止(超过七年)的文献中最长的报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号